[EN] SUBSTITUTED 2-ARYLMETHYLENE-N-ARYL-N'-ARYL-MALONAMIDES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS [FR] MALONAMIDES 2-ARYLMETHYLENE-N-ARYL-N'-ARYL SUBSTITUES ET LEURS ANALOGUES UTILES COMME ACTIVATEURS DES CASPASES ET INDUCTEURS DE L'APOPTOSE
The present invention provides a compound represented by the formula (1):
wherein
R
1
, R
2
and R
5
are each independently selected from a hydrogen atom, a halogen atom, a C
1
-C
6
alkyl is substituted with a halogen atom and the like;
R
3
and R
4
are each independently selected from a hydrogen atom, a halogen atom, a substituted C
1
-C
6
alkyl group and the like;
R
6
and R
7
are each independently selected from a hydrogen atom and a halogen atom;
Z
1
and Z
2
are each independently selected from a hydrogen atom, a hydroxyl group and —O(CHR
11
)OC(═O)R
12
;
Q is a group of the formula:
(wherein
G
1
is C—Y
2
or N;
a ring A is a benzene ring or a 5- to 6-membered unsaturated heterocycle)
a pharmaceutically acceptable salt thereof or a prodrug thereof.
Substituted 2-arylmethylene-n-aryl-n'aryl-malonamides and analogs as activators of caspases and inducers of apoptosis
申请人:Cai Xiong Sui
公开号:US20070043076A1
公开(公告)日:2007-02-22
The present invention is directed to substituted 2-arylmethylene-N-aryl-N′-aryl-malonamides and analogs thereof. The present invention also relates to the discovery that the compounds are activators of caspases and inducers of apoptosis. Therefore, the activators os caspases and inducers of apoptosis of this invention can be used to induce cell death in a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.
The present invention provides a compound represented by the formula (1):
wherein
R1, R2 and R5 are each independently selected from a hydrogen atom, a halogen atom, a C1-C6 alkyl is substituted with a halogen atom and the like;
R3 and R4 are each independently selected from a hydrogen atom, a halogen atom, a substituted C1-C6 alkyl group and the like;
R6 and R7 are each independently selected from a hydrogen atom and a halogen atom;
Z1 and Z2 are each independently selected from a hydrogen atom, a hydroxyl group and -O(CHR11)OC(=O)R12;
Q is a group of the formula:
(wherein
G1 is C-Y2 or N;
a ring A is a benzene ring or a 5- to 6-membered
unsaturated heterocycle)
a pharmaceutically acceptable salt thereof or a prodrug thereof.
[EN] SUBSTITUTED 2-ARYLMETHYLENE-N-ARYL-N'-ARYL-MALONAMIDES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS<br/>[FR] MALONAMIDES 2-ARYLMETHYLENE-N-ARYL-N'-ARYL SUBSTITUES ET LEURS ANALOGUES UTILES COMME ACTIVATEURS DES CASPASES ET INDUCTEURS DE L'APOPTOSE